Research article

Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study

Nicola Bizzaro^*^†, Elena Bartoloni^†, Gabriella Morozzi, Stefania Manganelli, Valeria Riccieri, Paola Sabatini, Matteo Filippini, Marilina Tampoia, Antonella Afeltra, Giandomenico Sebastiani, Claudia Alpini, Vittorio Bini, Onelia Bistoni, Alessia Alunno, Roberto Gerli and the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA Group)

* Corresponding author: Nicola Bizzaro nicola.bizzaro@ass3.sanita.fvg.it
† Equal contributors

Arthritis Research & Therapy 2013, 15:R16 doi:10.1186/ar4148

Accesses

Last 30 days: 425 accesses
Last 365 days: 2303 accesses
All time: 2303 accesses

Arthritis Research & Therapy

Viewing options

Associated material

Tools

Share this article

Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study

Accesses

Cited by

BioMed Central: 1 citation

Google Scholar: View citations

PubMed Central: View citations

Arthritis Research & Therapy

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Share this article

Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study

Accesses

Cited by

BioMed Central: 1 citation

Google Scholar: View citations

PubMed Central: View citations